Answers are grounded in this paper and cite their sources.
Purpose: This study compares the efficacy and safety of conventional versus accelerated corneal collagen cross linking in treatment of progressive keratoconus.Methods: This non-randomized interventional study was conducted on 79 eyes with keratoconus or corneal ectatic diseases. Patients’ eyes were divided into two groups, group A (n=35 eyes) underwent conventional crosslinking (cCXL) and group B (n=44 eyes) underwent the accelerated (KXL) technique. Results: No eyes lost any lines of visual acuity and more than 80% gained 1-4 lines in both UCVA and BCVA in both groups. Comparing both groups after 6 months, a more significant decrease in ECD was seen in the accelerated group at 6months (p=0.011), the mean cylindrical error showed a more significant improvement in the accelerated group (p=0.044), less reduction of pachymetry at thinnest location in KXL (P=0.008), but the mean depth of the demarcation line was significantly better and more homogenous in the conventional group (363.57±46.92µm) than the accelerated group (319.56±36.50µm) (P<0.001). Both groups showed insignificant change in the coefficient of variation for specular microscopy (P=0.574 and 0.528).Conclusion: both types offer a significant improvement in UCVA and BCVA values, but cCXL offers a deeper demarcation line and less endothelial loss. KXL offers less reduction in pachymetry and better cylinder correction.
No takes yet. Share an insight, caveat, or question.
ElShiwy et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: